Sánchez-Ortega, I
Querol, S
Encuentra, M
Ortega, S
Serra, A
Sanchez-Villegas, J M
Grifols, J R
Pujol-Balaguer, M M
Pujol-Bosch, M
MartÃ, J M
Garcia-Cerecedo, T
Barba, P
Sancho, J M
Esquirol, A
Sierra, J
Duarte, R F
Article History
Received: 26 March 2014
Revised: 15 July 2014
Accepted: 18 July 2014
First Online: 15 September 2014
Competing interests
: RFD reports honoraria as a speaker and advisory board member for Genzyme-Sanofi, Amgen and Italfarmaco, whose products are discussed here. The remaining authors report no relevant conflict of interest.